Formuepleje A S Sells 8,078 Shares of Agilent Technologies, Inc. $A

Key Points

• Formuepleje A S reduced its Agilent Technologies position by 27.2%, selling 8,078 shares and retaining 21,641 shares valued at approximately $3.73 million. Institutional investors and hedge funds collectively own 87.41% of the company.
• Agilent reported quarterly EPS of $1.62, beating estimates of $1.49, while revenue rose 8.1% year over year to $1.88 billion. The company issued fiscal 2026 EPS guidance of $6.18–$6.21 and announced a quarterly dividend of $0.255 per share.
• Analyst sentiment remains generally positive: 15 analysts rate the stock Buy and four rate it Hold, with an average price target of $173.65. Agilent also agreed to acquire Proscia for up to $270 million, expanding its digital pathology and AI-enabled diagnostics capabilities.

Formuepleje A S trimmed its position in Agilent Technologies, Inc. (NYSE:A - Free Report) by 27.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 21,641 shares of the medical research company's stock after selling 8,078 shares during the quarter. Formuepleje A S's holdings in Agilent Technologies were worth $3,729,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of A. SHP Wealth Management acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $26,000. Cedar Mountain Advisors LLC bought a new position in shares of Agilent Technologies during the 1st quarter worth approximately $27,000. Markowski Investments acquired a new position in shares of Agilent Technologies during the 2nd quarter worth approximately $27,000. MV Capital Management Inc. acquired a new position in shares of Agilent Technologies during the 4th quarter worth approximately $28,000. Finally, Keating Financial Advisory Services Inc. bought a new stake in Agilent Technologies in the 2nd quarter valued at $31,000. 87.41% of the stock is currently owned by institutional investors and hedge funds.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Analysts raised their targets: Morgan Stanley increased its target from $175 to $190 and maintained an “overweight” rating. TD Cowen raised its target from $180 to $196 and upgraded or maintained the stock at “buy.” The revisions signal expectations for continued earnings growth and approximately 9%–12% potential upside from recent trading levels. Morgan Stanley Forecasts Strong Price Appreciation for Agilent Technologies Stock TD Cowen Adjusts Price Target on Agilent Technologies
• Positive Sentiment: Proscia acquisition expands Agilent’s digital-health strategy: Agilent agreed to acquire pathology software company Proscia for $240 million upfront, with total consideration potentially reaching $270 million through milestone payments. Proscia’s AI-enabled digital pathology technology could broaden Agilent’s offerings and provide exposure to software-driven diagnostics and scientific intelligence. Agilent Technologies to Acquire Proscia
• Positive Sentiment: Favorable industry backdrop: A market report projects a 17.3% compound annual growth rate for global metabolomics through 2030, potentially supporting demand for Agilent’s analytical instruments and AI-enabled laboratory solutions. Global Metabolomics Market Report 2026
• Neutral Sentiment: China expansion: Agilent plans to expand its capabilities in China, which could create longer-term growth opportunities but also leaves the company exposed to regional regulatory, competitive and geopolitical risks. Agilent to Expand Capabilities in China
• Negative Sentiment: Investors will monitor acquisition execution: The Proscia transaction adds spending and integration obligations, and its benefits may take time to materialize. The deal’s ultimate value could rise to $270 million if milestones are achieved.

Insider Activity

In related news, Director Mikael Dolsten sold 634 shares of the company's stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.17% of the company's stock.

Analyst Ratings Changes

Several brokerages have issued reports on A. Citigroup raised their price target on Agilent Technologies from $185.00 to $190.00 and gave the company a "buy" rating in a report on Thursday, August 27th. Wall Street Zen downgraded shares of Agilent Technologies from a "buy" rating to a "hold" rating in a report on Saturday, October 3rd. Morgan Stanley increased their price objective on shares of Agilent Technologies from $175.00 to $190.00 and gave the company an "overweight" rating in a research report on Tuesday. Sanford C. Bernstein increased their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an "outperform" rating in a research report on Thursday, August 27th. Finally, Royal Bank Of Canada raised their target price on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an "outperform" rating in a research note on Thursday, August 27th. Fifteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $173.65.

Agilent Technologies Stock Performance

Shares of NYSE A traded up $2.16 during trading hours on Thursday, reaching $176.16. 441,599 shares of the stock were exchanged, compared to its average volume of 2,257,792. The firm has a market capitalization of $49.66 billion, a price-to-earnings ratio of 34.61, a P/E/G ratio of 2.61 and a beta of 1.21. The stock's fifty day simple moving average is $157.78 and its 200 day simple moving average is $136.84. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $177.05.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same period in the previous year, the company posted $1.37 EPS. The firm's quarterly revenue was up 8.1% on a year-over-year basis. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 6.20 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 28th. Stockholders of record on Tuesday, October 6th will be given a $0.2550 dividend. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Tuesday, October 6th. Agilent Technologies's payout ratio is presently 20.08%.

Agilent Technologies Company Profile

Agilent Technologies, Inc is an analytical measurement and laboratory technology company serving the life sciences, diagnostics, pharmaceutical, chemical, environmental, food, energy and academic research markets. Its solutions help laboratories analyze the composition, quality and performance of materials, biological samples and other substances.

The company's products and services include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy equipment, laboratory automation tools, software, consumables and supplies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.